...
首页> 外文期刊>Cell cycle >ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial-mesenchymal transition and enhancing DNA damage
【24h】

ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial-mesenchymal transition and enhancing DNA damage

机译:Zeb1抑制通过消除上皮 - 间充质转变和增强DNA损伤,使细胞对ATR抑制剂Ve-821感染

获取原文
获取原文并翻译 | 示例
           

摘要

The ataxia-telangiectasia-mutated (ATM) and rad3-related (ATR) checkpoint pathway plays an essential role in modulating cellular responses to replication stress and DNA damage to maintain genomic stability. In various tumors, cancer cells have increased dependence on ATR signaling for survival, making ATR a promising target for cancer therapy. ATR inhibitors sensitize multiple tumor cell types to radiation and DNA-damaging agents, but application of an ATR inhibitor alone shows limited efficacy. In the present study, we investigated the role of epithelial-to-mesenchymal transition (EMT) and the EMT transcription factor ZEB1 in regulating cell sensitivity to the ATR inhibitor VE-821. We found that VE-821 induced EMT with concomitant ZEB1 upregulation and promoted migration in cells in which the anti-proliferative effect of VE-821 was limited. Knocking down ZEB1 using siRNA partially reversed VE-821-induced EMT, and sensitized cells to VE-821 via effective attenuation of migration and AKT/ERK signaling. Moreover, ZEB1 inhibition promoted Chk1 phosphorylation and induced S-phase arrest by enhancing TopBP1 expression, which suggests a distinctive modulatory effect of ZEB1 on Chk1. Finally, combining VE-821 with ZEB1 inhibition enhanced DNA damage accumulation. These results demonstrate that EMT represents a novel mechanism for limiting the effectiveness of an ATR inhibitor, and thus suggest that ZEB1 inhibition might represent a new approach to increasing the efficiency of, or reversing resistance to, ATR inhibitors.
机译:共济失调毛细血管扩张突变(ATM)和rad3相关(ATR)检查点通路在调节细胞对复制应激和DNA损伤的反应以维持基因组稳定性方面起着重要作用。在各种肿瘤中,癌细胞对ATR信号的依赖性增加,使ATR成为癌症治疗的一个有希望的靶点。ATR抑制剂使多种肿瘤细胞对辐射和DNA损伤剂敏感,但仅应用ATR抑制剂的效果有限。在本研究中,我们研究了上皮-间充质转化(EMT)和EMT转录因子ZEB1在调节细胞对ATR抑制剂VE-821敏感性中的作用。我们发现,在VE-821的抗增殖作用有限的细胞中,VE-821诱导EMT并伴随ZEB1上调,并促进迁移。使用siRNA敲除ZEB1部分逆转了VE-821诱导的EMT,并通过有效抑制迁移和AKT/ERK信号使细胞对VE-821敏感。此外,ZEB1抑制通过增强TopBP1表达促进Chk1磷酸化并诱导S期阻滞,这表明ZEB1对Chk1具有独特的调节作用。最后,结合VE-821和ZEB1抑制增强了DNA损伤累积。这些结果表明,EMT代表了一种限制ATR抑制剂有效性的新机制,因此表明ZEB1抑制可能代表了一种提高ATR抑制剂效率或逆转其耐药性的新方法。

著录项

  • 来源
    《Cell cycle》 |2018年第5期|共10页
  • 作者单位

    China Med Univ Dept Med Oncol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Oncol Shengjing Hosp Shenyang 110004 Liaoning Peoples R China;

    China Med Univ Dept Med Oncol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Med Oncol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Med Oncol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    Dalian Univ Dept Oncol Affiliated Zhongshan Hosp Dalian 116001 Peoples R China;

    China Med Univ Dept Med Oncol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Med Oncol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Med Oncol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Med Oncol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Med Oncol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Med Oncol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Med Oncol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学;
  • 关键词

    ATR; Chk1; EMT; ZEB1; ATR inhibitor; sensitivity; DNA damage;

    机译:ATR;CHK1;EMT;Zeb1;ATR抑制剂;敏感性;DNA损伤;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号